MARTYNOSIDE manufacturers
- MARTYNOSIDE
-
- $0.00 / 25kg
-
2024-04-12
- CAS:67884-12-2
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 2000ton
- MARTYNOSIDE
-
- $0.00 / 25kg
-
2024-04-12
- CAS:67884-12-2
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 2000ton
- Martynoside
-
- $0.00 / 5mg
-
2023-02-24
- CAS:67884-12-2
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
|
| | MARTYNOSIDE Basic information |
| Product Name: | MARTYNOSIDE | | Synonyms: | MARTYNOSIDE;1-O-(3-Hydroxy-4-methoxyphenethyl)-3-O-(α-L-rhamnopyranosyl)-β-D-glucopyranose 4-(3-methoxy-4-hydroxy-trans-cinnamate);2-(3-Hydroxy-4-methoxyphenyl)ethyl 3-O-(α-L-rhamnopyranosyl)-4-O-[(E)-3-(4-hydroxy-3-methoxyphenyl)acryloyl]-β-D-glucopyranoside;3-Hydroxy-4-methoxyphenethyl 3-O-α-L-rhamnopyranosyl-4-O-(3-methoxy-4-hydroxy-trans-cinnamoyl)-β-D-glucopyranoside;Martyside;β-D-Glucopyranoside, 2-(3-hydroxy-4-methoxyphenyl)ethyl 3-O-(6-deoxy-α-L-mannopyranosyl)-, 4-[(2E)-3-(4-hydroxy-3-methoxyphenyl)-2-propenoate];(2R,3R,4R,5R,6R)-5-hydroxy-6-[2-(3-hydroxy-4-methoxyphenyl)ethoxy]-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl](E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate | | CAS: | 67884-12-2 | | MF: | C31H40O15 | | MW: | 652.64 | | EINECS: | | | Product Categories: | | | Mol File: | 67884-12-2.mol |  |
| | MARTYNOSIDE Chemical Properties |
| Boiling point | 865.1±65.0 °C(Predicted) | | density | 1.48±0.1 g/cm3(Predicted) | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | pka | 9.73±0.31(Predicted) | | form | Powder | | color | White to off-white | | Cosmetics Ingredients Functions | SKIN PROTECTING
ANTIOXIDANT
SKIN CONDITIONING | | InChIKey | WLWAYPFRKDSFCL-OQPPUVGONA-N |
| | MARTYNOSIDE Usage And Synthesis |
| Uses | Martynoside protects ex vivo bone marrow cells from 5-fluorouracil (5-FU)-induced cell death and inflammation response by down-regulating the TNF signaling pathway[1].Martynoside is a potent antiestrogen in MCF-7 cells, increasing IGFBP3 levels | | target | Estrogen receptor | ROS | Progestogen receptor | | References | [1] Hong M, et al. Ex vivo and in vivo chemoprotective activity and potential mechanism of Martynoside against 5-fluorouracil-induced bone marrow cytotoxicity.Biomed Pharmacother. 2021;138:111501. DOI:10.1016/j.biopha.2021.111501
[2] Papoutsi Z,et al. Acteoside and martynoside exhibit estrogenic/antiestrogenic properties.J Steroid Biochem Mol Biol. 2006;98(1):63-71. DOI:10.1016/j.jsbmb.2005.07.005 |
| | MARTYNOSIDE Preparation Products And Raw materials |
|